Niagen Bioscience, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $68.3M
Liabilities Breakdown FY2024
Total Liabilities: $22.2M
Asset Breakdown
Total Assets: $68.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $44.5M | 65.2% |
| Accounts Receivable | $7.8M | 11.4% |
| Inventory | $9.2M | 13.5% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $359.0K | 0.5% |
| Other Assets | $6.5M | 9.5% |
Liabilities Breakdown
Total Liabilities: $22.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.5M | 38.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.7M | 61.6% |